81 related articles for article (PubMed ID: 1617998)
1. Cefonicid versus cefuroxime: an in vitro study of 1,000 Enterobacteriaceae.
Keness J; Efrati Z; Raz R
Chemotherapy; 1992; 38(1):14-6. PubMed ID: 1617998
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of cefonicid compared to other antibiotics against clinical bacterial isolates.
Verbist L; Verhaegen J
Acta Clin Belg; 1990; 45(2):113-9. PubMed ID: 2164309
[TBL] [Abstract][Full Text] [Related]
3. Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime.
Tartaglione TA; Polk RE
Drug Intell Clin Pharm; 1985 Mar; 19(3):188-98. PubMed ID: 3884304
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity of HR-756, cefoxitin and cefuroxine against multiply antibiotic-resistant strains of Enterobacteriaceae and Pseudomonas aeruginosa.
Legakis NJ; Kafetzis DA; Papadatos CJ; Papavassiliou JT
Chemotherapy; 1980; 26(5):334-43. PubMed ID: 6248301
[TBL] [Abstract][Full Text] [Related]
5. Ecological impact of ampicillin and cefuroxime in neonatal units.
Tullus K; Burman LG
Lancet; 1989 Jun; 1(8652):1405-7. PubMed ID: 2567427
[TBL] [Abstract][Full Text] [Related]
6. Cefonicid, a long acting cephalosporin: in vitro activity compared with three cephalosporins and gentamicin.
Hamilton-Miller JM; Patel R; Brumfitt W
Drugs Exp Clin Res; 1986; 12(11):861-9. PubMed ID: 3816503
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of combined cefotaxime and desacetyl-cefotaxime against aerobic and anaerobic gram-negative bacilli.
Marone P; Navarra A; Monzillo V; Traverso A
Drugs Exp Clin Res; 1990; 16(12):629-33. PubMed ID: 2130005
[TBL] [Abstract][Full Text] [Related]
8. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
Mascellino MT; Prignano G; Iegri F; Lorenzi A
Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
[TBL] [Abstract][Full Text] [Related]
9. [A comparative study of antibacterial activity of ceftibuten, ceftazidime, cefuroxime and ampicillin against clinical isolates].
Ergova R; K'oleian E; Kharalambieva Ia; Mitov I; Docheva Iu
Vutr Boles; 2000; 32(1):13-7. PubMed ID: 11195191
[TBL] [Abstract][Full Text] [Related]
10. A survey of the sensitivity of fresh clinical isolates to cefuroxime and other antibiotics.
Potaschmacher LO; Dash CH; Jefferson KA; Kennedy MR
J Clin Pathol; 1979 Sep; 32(9):944-50. PubMed ID: 512055
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
Skar AG; Midtvedt T; Dahl O
NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the sensitivity of selected bacterial strains to cefuroxime].
Pawluch D; Nowakowska K; Szozda G
Pol Tyg Lek; 1986 Sep; 41(37):1184-5. PubMed ID: 3103111
[No Abstract] [Full Text] [Related]
13. Activity of cefepime compared with other antibiotics against gram-positive bacteria and cefuroxime-resistant gram-negative bacteria.
Wang FD; Liu IM; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):408-13. PubMed ID: 9699393
[TBL] [Abstract][Full Text] [Related]
14. [In-vitro activity of cefonicid on hospital bacteria. Regression line and proposal for critical values].
Chanal M; Cluzel M; Sirot D; Joly B; Sirot J; Cluzel R
Pathol Biol (Paris); 1986 May; 34(5):385-9. PubMed ID: 3095773
[TBL] [Abstract][Full Text] [Related]
15. Lytic activity of a new cephalosporin, cefuroxime, against gram-negative bacteria.
Russell AD; Tottle PC
Chemotherapy; 1978; 24(6):354-9. PubMed ID: 359269
[TBL] [Abstract][Full Text] [Related]
16. Activities of cefoperazone, cefotaxime, cefuroxime, and cephalothin against 128 clinical isolates.
Garcia-Rodriguez JA
Clin Ther; 1980; 3(Spec Issue):117-22. PubMed ID: 6248220
[No Abstract] [Full Text] [Related]
17. Antagonism between cefoxitin and cefuroxime.
Chattopadhyay B; Hall I
J Antimicrob Chemother; 1979 Jul; 5(4):490-1. PubMed ID: 489501
[No Abstract] [Full Text] [Related]
18. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
Thabaut A; Durosoir JL; Saliou P
Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496
[TBL] [Abstract][Full Text] [Related]
19. Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli.
Chang UI; Kim HW; Wie SH
Korean J Intern Med; 2016 Jan; 31(1):145-55. PubMed ID: 26767868
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study of the in vitro activity of dibekacin, piperacillin, cefotaxime and cefuroxime on gram-negative bacteria].
Carlone NA; Cuffini AM; Forno-Pizzoglio M
G Batteriol Virol Immunol; 1983; 76(7-12):239-45. PubMed ID: 6099296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
